Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STFC
2151
DELISTED
State Auto Financial Corp
STFC
| $3.1M | ﹤0.01% |
91,045
+2,867
| +3% | +$93.5K |
|
2152
Akebia Therapeutics
AKBA
$354M
| $3.1M | ﹤0.01% |
560,260
+210,638
| +60% | +$1.65M |
|
2153
Tilly's
TLYS
$116M
| $3.1M | ﹤0.01% |
285,066
+215,226
| +308% | +$3.19M |
|
|
ORIT
2154
DELISTED
Oritani Financial Corp. New
ORIT
| $3.08M | ﹤0.01% |
208,997
-6,832
| -3% | -$103K |
|
2155
Camden National
CAC
$978M
| $3.07M | ﹤0.01% |
85,258
-776
| -0.9% | -$31.1K |
|
|
MCHB
2156
Mechanics Bancorp
MCHB
$3.72B
| $3.06M | ﹤0.01% |
144,353
+2,188
| +2% | +$55.3K |
|
|
WAIR
2157
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $3.06M | ﹤0.01% |
387,809
-32,540
| -8% | -$321K |
|
2158
Titan Machinery
TITN
$396M
| $3.05M | ﹤0.01% |
231,822
+44,089
| +23% | +$656K |
|
|
DBD
2159
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.04M | ﹤0.01% |
1,222,439
+294,236
| +32% | +$1.05M |
|
|
DVAX
2160
DELISTED
Dynavax Technologies
DVAX
| $3.04M | ﹤0.01% |
331,957
+7,510
| +2% | +$83.1K |
|
2161
Center Bancorp
CNOB
$1.66B
| $3.03M | ﹤0.01% |
163,909
+1,127
| +0.7% | +$23.1K |
|
|
DRNA
2162
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.02M | ﹤0.01% |
282,967
+53,037
| +23% | +$698K |
|
2163
Banc of California
BANC
$3.03B
| $3.01M | ﹤0.01% |
226,351
-1,524
| -0.7% | -$24.7K |
|
|
VTLE
2164
DELISTED
Vital Energy
VTLE
| $3.01M | ﹤0.01% |
41,601
-957
| -2% | -$100K |
|
2165
Verra Mobility
VRRM
$804M
| $3.01M | ﹤0.01% |
+308,329
| New | +$3.11M |
|
|
STEL
2166
DELISTED
Stellar Bancorp
STEL
| $3M | ﹤0.01% |
102,139
+2,720
| +3% | +$90.2K |
|
|
LION
2167
DELISTED
Fidelity Southern Corporation
LION
| $3M | ﹤0.01% |
115,151
-1,150
| -1% | -$27.1K |
|
2168
Argan
AGX
$8B
| $2.99M | ﹤0.01% |
79,077
-35,882
| -31% | -$1.52M |
|
2169
PLDT
PHI
$4.25B
| $2.99M | ﹤0.01% |
+139,979
| New | +$3.3M |
|
|
BFYT
2170
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $2.98M | ﹤0.01% |
111,274
+42,738
| +62% | +$1.71M |
|
2171
Ternium
TX
$9.67B
| $2.97M | ﹤0.01% |
109,566
-7,657
| -7% | -$228K |
|
2172
Ecovyst
ECVT
$1.32B
| $2.96M | ﹤0.01% |
199,513
+404
| +0.2% | +$6.21K |
|
|
GBNK
2173
DELISTED
Guaranty Bancorp
GBNK
| $2.95M | ﹤0.01% |
142,142
+330
| +0.2% | +$8.41K |
|
2174
Myers Industries
MYE
$1.29B
| $2.94M | ﹤0.01% |
194,794
+511
| +0.3% | +$8.38K |
|
|
ATNX
2175
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.94M | ﹤0.01% |
11,597
-148
| -1% | -$37.7K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.